Quick Answer
Health Catalyst, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $311.14 million for the year ending 2025.
- Health Catalyst, Inc. showed an increase of +1.5% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Health Catalyst, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $22.99 million | Q3 2018: $32.87 million | Q1 2019: $35.21 million | Q2 2019: $36.80 million | Q3 2019: $39.42 million | Q1 2020: $45.12 million | Q2 2020: $43.26 million | Q3 2020: $47.19 million | Q1 2021: $55.85 million | Q2 2021: $59.63 million | Q3 2021: $61.74 million | Q1 2022: $68.09 million | Q2 2022: $70.63 million | Q3 2022: $68.35 million | Q1 2023: $73.87 million | Q2 2023: $73.21 million | Q3 2023: $73.77 million | Q1 2024: $74.72 million | Q2 2024: $75.90 million | Q3 2024: $76.35 million | Q1 2025: $79.41 million | Q2 2025: $80.72 million | Q3 2025: $76.32 million.
- Over the full 9 years of available data (2017 to 2025), Health Catalyst, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 325.7%.
- Historical annual values: Fiscal year 2025: $311.14 million | Fiscal year 2024: $306.58 million | Fiscal year 2023: $295.94 million | Fiscal year 2022: $276.24 million | Fiscal year 2021: $241.93 million | Fiscal year 2020: $188.85 million | Fiscal year 2019: $154.94 million | Fiscal year 2018: $112.57 million | Fiscal year 2017: $73.08 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: